Arthritis & Rheumatism

A protein that controls inflammation

A study by the research team of Prof. Geert van Loo (VIB-UGent Center for Inflammation Research) has unraveled a critical molecular mechanism behind autoimmune and inflammatory diseases such as rheumatoid arthritis, Crohn's ...

Psychology & Psychiatry

Inflammation links heart disease and depression, study finds

People with heart disease are more likely to suffer from depression, and the opposite is also true. Now, scientists at the University of Cambridge believe they have identified a link between these two conditions: inflammation—the ...

Medical research

Study puts a new spin on ibuprofen's actions

Ibuprofen, naproxen, and related non-steroidal anti-inflammatory drugs (NSAIDs) – the subjects of years of study – still have some secrets to reveal about how they work.

Neuroscience

Discovery reveals blocking inflammation may lead to chronic pain

Using anti-inflammatory drugs and steroids to relieve pain could increase the chances of developing chronic pain, according to researchers from McGill University and colleagues in Italy. Their research puts into question ...

Medications

Cheap drug is first shown to improve COVID-19 survival

Researchers in England say they have the first evidence that a drug can improve COVID-19 survival: A cheap, widely available steroid reduced deaths by up to one third in severely ill hospitalized patients.

Arthritis & Rheumatism

Quadriceps exercise relieves pain in knee osteoarthritis

(HealthDay)—A quadriceps isometric contraction exercise method is effective for relieving pain in knee osteoarthritis (OA), according to a study published online May 25 in the International Journal of Rheumatic Diseases.

Inflammatory disorders

Empowering mucosal healing with an engineered probiotic

About 1.6 million people in the US alone currently have lifelong and incurable Inflammatory Bowel Disease (IBD) including Crohn's disease and ulcerative colitis, and 70,000 new cases are diagnosed in the USA each year. IBD ...

Diseases, Conditions, Syndromes

WHO prequalifies arthritis drug for severe COVID cases

The World Health Organization said Friday that it had prequalified the arthritis treatment tocilizumab for use in patients hospitalised with severe COVID-19, in a bid to increase access to the pricey drug.

page 2 from 28